Sign up Canada
Proactive Investors - Run By Investors For Investors

Smith & Nephew shares rally slightly despite a Deutsche Bank downgrade after results disappointment

The German bank’s analysts cut their stance on the FTSE 100-listed artificial hips and knees maker to ‘sell’ from ‘hold’ and reduced their target price to 1,200p from 1.315p
Knees x-ray
Smith & Nephew shares slumped by around 8% yesterday after it reported flat underlying revenue for the first three months of the year

Smith & Nephew PLC (LON:SN.) shares edged higher on Friday following big falls after disappointing first-quarter results in the previous session, despite a downgrade in rating by Deutsche Bank.

The German bank’s analysts cut their stance on the FTSE 100-listed artificial hips and knees maker to ‘sell’ from ‘hold’ and reduced their target price for the stock to 1,200p from 1.315p.

READ: Smith & Nephew cuts full year revenue guidance after weaker first quarter

In a note to clients, they said: “We expect shares in S&N to de-rate from ~19x 1-yr fwd P/E to ~17x 1-yr fwd P/E.

“This reflects our view that the company can only deliver low single-digit earnings growth and that the visibility of this growth may reduce further.”

Smith & Nephew shares slumped by around 8% yesterday after it reported flat underlying revenue for the first three months of the year, well below analysts’ expectations for growth of 1.6%.

However, in late morning trading on Friday, the shares edged up 0.2% to 1,304.5p.

View full SN. profile View Profile

Related Articles

scientist with vial
September 25 2018
The AIM-listed drug developer is at the vanguard of advances in the emerging field of immuno-oncology
Laboratory
June 21 2018
Genedrive has signed sales agreement with Sysmex Corporation for the distribution of the HCV ID to EMEA and Asia Pacific and with Mumbai- based ARKRAY to distribute the kit in India
tumour cells
July 25 2018
Sign-off by the US Food & Drug Administration is considered the "global standard for approval", the company said

No investment advice

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You understand that the Company receives either monetary or securities compensation for our services. We stand to benefit from any volume this write-up may generate.

You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter.

You understand that the Site may contain opinions from time to time with regard to securities mentioned in other products, including company related products, and that those opinions may be different from those obtained by using another product related to the Company. You understand and agree that contributors may write about securities in which they or their firms have a position, and that they may trade such securities for their own account. In cases where the position is held at the time of publication and such position is known to the Company, appropriate disclosure is made. However, you understand and agree that at the time of any transaction that you make, one or more contributors may have a position in the securities written about. You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

Copyright © Proactiveinvestors.com, 2018. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use